A simple, reliable HPLC method using fluorescence detection (excitation 307 and emission 483 nm) was developed and validated for simultaneous quantitation of zopiclone and its metabolite desmethylzopiclone in human plasma. Following a single-step liquid-liquid extraction, the analytes and internal s
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection
β Scribed by T. Dine; C. Brunet; M. Luyckx; M. Cazin; P. Gosselin; J. L. Cazin
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 364 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0269-3879
No coin nor oath required. For personal study only.
β¦ Synopsis
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known fluorescent metabolites epirubicinol, 4'-O-~-~-glucuronyl-4'-epidoxorubicin and 4'-O-fi-D-ghCUrOnyl 1,3-dihydro-4'-epidoxorubicin, with daunorubicin as an internal standard, by using high performance liquid chromatography (HPLC) with fluorescence detection and a 'Hypersil ODs' column. The drugs were easily and efficiently extracted with a Sep-Pak C,* cartridge and the mean recoveries were greater than 85%. Intraassay and Interassay coefficients of variation (plasma samples) were better than 8.25%. An example of pharmacokinetic study obtained in a cancer patient after intravenous injection of epirubicine is described.
π SIMILAR VOLUMES
## Abstract An assay for the measurement of unbound Lβtryptophan concentrations in plasma was developed using reverseβphase HPLC with fluorescence detection. Unbound Lβtryptophan from plasma was obtained using the Amicon MPSβ1 ultrafiltration device. Lβtryptophan binding to the membrane in the ultr
Atrasentan is an endothelin antagonist selective for the ET A receptor in development at Abbott Laboratories for the treatment of cardiovascular disease and cell proliferation disorders. A simple and sensitive chromatographic method for the determination of atrasentan in human plasma has been develo